/NOT FOR DISSEMINATION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/
David Rendimonti to assume the role of Chief Executive Officer
OTTAWA, Oct. 5, 2018 /CNW Telbec/ - LiveWell Canada Inc. ("LiveWell" or the "Company") (TSXV: LVWL) (OTC: LXLLF), is pleased to announce that healthcare leader Mr. David Rendimonti, in addition to his role as President, will also assume responsibilities as Chief Executive Officer, effective immediately.
The move is part of LiveWell's vision to become a world leader in health and wellness through quality outcomes and strategic partnerships. LiveWell is an innovative Canadian hemp and cannabis company focused on advanced research on CBD and other cannabinoids, as well as developing and distributing prescription and consumer health products supported by data, discovery, science and technology.
Seann Poli, Co-Founder, Chief Executive Officer and Director of LiveWell, becomes a Special Advisor to the Company. In his new role, Mr. Poli will continue his focus on capital markets efforts including communicating with dealers, brokers and other market participants. Mr. Poli will also continue to undertake searching for strategic partnerships and acquisitions, a community outreach program, coordinating relationships with various entities including the City of Ottawa, other municipalities, national and international organizations, and charities.
Tim McCunn, Chairman of LiveWell Canada, stated, "As a fellow Co-Founder, Seann has been instrumental in creating an organization with a significant asset base and strategic partners. He will continue to focus on these areas and further value-creation opportunities for LiveWell."
Seann Poli, commented, "David has a consistent track record of building high performance teams and top brands that are both best in class and industry. His performance has been consistently delivered through highly creative, strategic, tactical and financial plans, as well as exceptional leadership and flawless execution. We welcome him to an expanded role with the LiveWell."
Mr. Rendimonti is a healthcare leader with a 30-year track record of building and leading No. 1 brands, including senior roles at some of the world's most prominent organizations such as Johnson & Johnson, Pfizer and Merck. Mr. Rendimonti drove innovation within the Biotech and Women's Health markets in Canada and has extensive experience in global health and wellness markets. His pioneering spirit, pursuit of innovation and background in capital markets makes him ideally suited to optimize the Company's growth trajectory in the fast-developing cannabis and hemp-based health and wellness markets worldwide.
In his role as President and Chief Executive Officer, Mr. Rendimonti will continue to focus on executing the Company's global health and wellness vision, including strategic partnerships, investments and developing LiveWell's prescription and consumer health products supported by data, discovery, science and technology.
About LiveWell Canada:
LiveWell Canada Inc. (TSXV: LVWL, OTC:LXLLF) is focused on improving health one person at a time utilizing innovation supported by data, discovery, science and technology. The cannabis and hemp company is conducting advanced research on CBD and other cannabinoids, as well as developing and distributing prescription and consumer health and wellness products. LiveWell is conducting major research on CBD, has completed a white paper on CBD from Industrial Hemp, and is also investing in technologies for the extraction and isolation of CBD and other cannabinoids for use in prescription and consumer health products. The Company has secured major supply agreements for industrial hemp biomass, and has more than 1.5 million square feet of greenhouse under construction in Ontario and Quebec. It is also supported by business partners such as Canopy Growth (TSX: WEED, NYSE:CGC) and Canopy Rivers (TSXV: RIV). For more information, visit livewellcorp.com.
Cautionary Note Regarding Forward-Looking Statements
This release includes forward-looking statements about the Company and its business. Often, but not always, forward-looking statements can be identified by the use of words such as "plan", "continue", "expect", "schedule", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements (including negative variations) that certain events or conditions "may" or "will" occur. Such statements are based on the current expectations of management. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of unknown and known risk factors and uncertainties affecting the Company, including risks regarding the cannabis and hemp industry, economic factors, the equity markets and risks associated with growth and competition. The Company cautions that this foregoing list of material factors is not exhaustive, and readers are encouraged to read all Risk Factors disclosed in the Company's Filing Statement dated May 29, 2018.
The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.
Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
For more information, visit livewellcorp.com.
SOURCE LiveWell Canada Inc.
For further information: Media, English, Deborah Stokes - 819 576-3789, firstname.lastname@example.org; French, Sonya Lord - 866 308-1518, email@example.com; Investors, Nicole Marchand - 416 428-3533, firstname.lastname@example.org; Company, David Rendimonti - President and CEO, Steven Archambault - Chief Financial Officer